Last reviewed · How we verify
Hemophilia A
Approved treatments
- Qfitlia · Genzyme Corp
Qfitlia works by using small RNA molecules to block the production of antithrombin, a protein that can interfere with blood clotting. - PF-07202954 Single Dose · Pfizer
- Xyntha · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hemophilia A patent landscape — cliff calendar, originator estates, attackable patents
- Hemophilia A treatment landscape brief
- Hemophilia A treatment updates RSS
Frequently asked questions about Hemophilia A
What drugs treat Hemophilia A?
Tracked treatments include Qfitlia, PF-07202954 Single Dose, Xyntha.
What is the treatment for Hemophilia A?
Standard treatment for Hemophilia A includes Qfitlia, PF-07202954 Single Dose, Xyntha. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hemophilia A patent cliff · Hemophilia A CI report
- Treatment: Qfitlia · Genzyme Corp
- Treatment: PF-07202954 Single Dose · Pfizer
- Treatment: Xyntha · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing